7-138802927-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001085429.2(TMEM213):c.182G>A(p.Arg61Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000209 in 1,595,872 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001085429.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM213 | NM_001085429.2 | c.182G>A | p.Arg61Gln | missense_variant | 3/3 | ENST00000442682.7 | NP_001078898.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM213 | ENST00000442682.7 | c.182G>A | p.Arg61Gln | missense_variant | 3/3 | 1 | NM_001085429.2 | ENSP00000390407 | P4 | |
TMEM213 | ENST00000397602.7 | c.179G>A | p.Arg60Gln | missense_variant | 3/3 | 1 | ENSP00000380727 | A2 | ||
TMEM213 | ENST00000458494.1 | c.110G>A | p.Arg37Gln | missense_variant | 2/2 | 4 | ENSP00000393891 | |||
TMEM213 | ENST00000413208.1 | c.154+1529G>A | intron_variant | 3 | ENSP00000401570 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000196 AC: 45AN: 230108Hom.: 1 AF XY: 0.000160 AC XY: 20AN XY: 125106
GnomAD4 exome AF: 0.000210 AC: 303AN: 1443536Hom.: 1 Cov.: 31 AF XY: 0.000212 AC XY: 152AN XY: 717220
GnomAD4 genome AF: 0.000203 AC: 31AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2022 | The c.182G>A (p.R61Q) alteration is located in exon 3 (coding exon 3) of the TMEM213 gene. This alteration results from a G to A substitution at nucleotide position 182, causing the arginine (R) at amino acid position 61 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at